Scott Olszewski
About Scott Olszewski
Scott Olszewski is the Senior Field Medical Director at BeiGene in Emeryville, California, with over 20 years of experience in the medical field, including roles at Kite Pharma, Genentech, and Tufts Medical Center.
Company
Scott Olszewski currently works at BeiGene in Emeryville, California as a Senior Field Medical Director. BeiGene is a global biotechnology company focused on developing and commercializing innovative molecularly targeted and immuno-oncological drugs.
Title
Scott Olszewski holds the position of Senior Field Medical Director at BeiGene. In this role, he contributes to the company's medical field operations, utilizing his extensive background in medical science liaison and nurse practitioner roles.
Education and Expertise
Scott Olszewski achieved his Master of Science (MS) in Family Nurse Practitioner from the MGH Institute of Health Professions between 1995 and 1998. He also holds a Bachelor of Science (BS) in Biology, General from Gettysburg College obtained from 1988 to 1992. He has over 20 years of professional experience in the medical field, with a specialized focus on medical science liaison and nurse practitioner positions.
Work Experience in Biotechnology and Pharmaceuticals
Scott Olszewski has held significant roles in the biotech and pharmaceutical industries. He worked as a Medical Science Liaison at Kite Pharma from 2016 to 2018 in Santa Monica, California. Before that, he spent 13 years at Genentech as a Senior Medical Science Liaison. His transition from clinical roles to corporate ones marked a significant shift in his career.
Professional Background in Healthcare
Scott Olszewski started his career as a Research Assistant at Joslin Diabetes Center, focusing on diabetes research from 1992 to 1995. He later worked as a Registered Nurse at Massachusetts General Hospital for 2 years and as a Nurse Practitioner at both McBrine & Vasconcellos P.C. and Tufts Medical Center. This extensive clinical background paved the way for his transition into the biotech and pharmaceutical sectors.